A large number of potentially therapeutic agents have been screened using these mutant SOD1 transgenic mice, based at least in part on the assumption that the disease mechanisms in S-ALS are similar to those in F-ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.